This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
The Current State of Play in Connected Devices
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions
Exploring a Faster, More Cost-Effective Alternative to Generic Bioequivalence
Publications, Pharmaceutical, Innovation & Insights, Product Solutions
New Tools to Advance CNS Drug Delivery
Webinars, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations, Market Insights
Aptar Pharma discusses challenges and benefits of drug repurposing
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions
